Literature DB >> 2472849

Quantitative detection of class-specific rheumatoid factors using mouse monoclonal antibodies and the biotin/streptavidin enhancement system.

H G Otten1, M R Daha, H H de Rooij, F C Breedveld.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) for the quantitative detection of rheumatoid factors (RF) was developed using mouse monoclonal antibodies against human IgG, IgA and IgM together with the biotin/streptavidin enhancement system. One hundred and eight patients with rheumatoid arthritis (RA) of whom 47 had a positive serum latex agglutination assay, 100 healthy controls and 95 diseased controls (25 systemic lupus erythematosus (SLE), 25 ankylosing spondylitis, 20 osteoarthritis and 25 bronchial asthma) were evaluated for the presence of IgG-, IgA- and IgM-RF by ELISA. Elevated levels of IgG-, IgA-, and IgM-RF could be demonstrated in respectively 94%, 91% and 98% of serum samples from RA patients with a positive latex test and in 72%, 69% and 8% of serum samples from RA patients with a negative latex test. In the latter patient group, increased levels of one or more RF isotypes could be detected in 82% of the patients. Except for the presence of IgG-RF in serum of 20% of the SLE patients, increased levels of RF isotypes were present in less than 5% of the diseased controls. Highly significant correlations were found between serum IgM-RF levels as detected by ELISA and those of the latex and the Rose-Waaler agglutination assays. Positive correlations were also found between the serum levels of the three RF isotypes investigated and between the levels of RF isotypes as measured in serum and synovial fluid of the same patient. Compared to agglutination assays, the ELISA for the quantitative detection of RF isotypes is a more reproducible and sensitive test which avoids some of the problems encountered in earlier ELISA methods.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472849     DOI: 10.1093/rheumatology/28.4.310

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  10 in total

1.  Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis.

Authors:  H Visser; L B Gelinck; A H Kampfraath; F C Breedveld; J M Hazes
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

2.  Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis.

Authors:  F Eggelmeijer; H G Otten; H H de Rooy; M R Daha; F C Breedveld
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  Rheumatoid factor production by mononuclear cells derived from different sites of patients with rheumatoid arthritis.

Authors:  H G Otten; M R Daha; R J Dolhain; H H de Rooy; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

4.  Diagnostic strategy for the assessment of rheumatoid vasculitis.

Authors:  A E Voskuyl; J M W Hazes; A H Zwinderman; E M Paleolog; F J M van der Meer; M R Daha; F C Breedveld
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

5.  Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis.

Authors:  L Kanerud; G N Engström; A Tarkowski
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

6.  IgA rheumatoid factor in mucosal fluids and serum of patients with rheumatoid arthritis: immunological aspects and clinical significance.

Authors:  H G Otten; M R Daha; M G van der Maarl; L I Hoogendoorn; E M Beem; H H de Rooy; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

7.  Uveitis and anti-neutrophil cytoplasmic antibodies.

Authors:  E C Hagen; H van de Vijver-Reenalda; R J de Keizer; A Kijlstra; L A van Es; M R Daha; F J van der Woude
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

8.  Human IgG Fc-binding phage antibodies constructed from synovial fluid CD38+ B cells of patients with rheumatoid arthritis show the imprints of an antigen-dependent process of somatic hypermutation and clonal selection.

Authors:  W J E Van Esch; C C Reparon-Schuijt; H J Hamstra; C Van Kooten; T Logtenberg; F C Breedveld; C L Verweij
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

9.  Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.

Authors:  D van Zeben; J M Hazes; A H Zwinderman; A Cats; E A van der Voort; F C Breedveld
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

10.  Plasminogen activators in synovial fluid and plasma from patients with arthritis.

Authors:  E J Brommer; G Dooijewaard; B A Dijkmans; F C Breedveld
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.